Drug and Medical Device Regulation Under the Trump Administration

Many of President Trump’s executive orders (EOs) and legislative measures have been designed to curtail federal regulation, reduce the size of the administrative state, and withdraw the U.S. from multilateral institutions. Here we examine how the President’s policy agenda—along with the approach of U.S. health secretary Robert F. Kennedy Jr—is impacting the U.S. Food and Drug Administration…
By: A&O Shearman